Group One Trading’s Precision BioSciences DTIL Stock Holding History

Group One Trading’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	-$1	–	7236
2023 Q4	–	Hold	0	–	–	–	7272
2023 Q3	–	Hold	0	–	–	–	7542
2023 Q2	–	Sell	-3	Closed	-$69	–	7761
2023 Q1	$63	Sell	3 -22	-88%	-$725	﹤0.01%	7056
2022 Q4	$876	Sell	25 -41	-62%	-$1.62K	﹤0.01%	6865
2022 Q3	$3K	Sell	66 -3	-4%	-$143	﹤0.01%	7009
2022 Q2	$3K	Buy	+69	New	+$4.05K	﹤0.01%	7281
2022 Q1	–	Sell	-31	Closed	-$4.21K	–	8167
2021 Q4	$7K	Sell	31 -505	-94%	-$141K	﹤0.01%	7513
2021 Q3	$186K	Buy	536 +255	+91%	+$86.4K	﹤0.01%	5249
2021 Q2	$106K	Sell	281 -5	-2%	-$1.5K	﹤0.01%	5888
2021 Q1	$89K	Buy	+286	New	+$100K	﹤0.01%	5758
2020 Q3	–	Sell	-9	Closed	-$1.79K	–	6179
2020 Q2	$2K	Buy	9 +5	+125%	+$1.09K	﹤0.01%	5547
2020 Q1	$1K	Sell	4 -191	-98%	-$50K	﹤0.01%	5069
2019 Q4	$81K	Buy	+195	New	+$61.3K	﹤0.01%	3766

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Group One Trading's DTIL Position: Q1 2024 in Review

Group One Trading held its Precision BioSciences (DTIL) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7236.

Group One Trading first reported a position in DTIL in Q4 2019 and has held it in 11 quarters since. The position peaked at $186K in Q3 2021. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Group One Trading held 0 shares of Precision BioSciences worth $0 as of Q1 2024.
Group One Trading left its Precision BioSciences share count unchanged in Q1 2024.
Precision BioSciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2024, its #7236 holding.
Group One Trading first reported a position in Precision BioSciences in Q4 2019 and has held it in 11 quarters since.
Group One Trading's Precision BioSciences position peaked at $186K in Q3 2021.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.